Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 4
2013 6
2014 4
2015 2
2016 2
2017 4
2018 7
2019 1
2020 1
2021 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
[Update from France Macula Federation: Diagnosis of wet AMD].
Wolff B, De Bats F, Tick S, Cornut PL, Souied É, Cohen SY. Wolff B, et al. Among authors: de bats f. J Fr Ophtalmol. 2018 Nov;41(9):857-861. doi: 10.1016/j.jfo.2018.05.004. Epub 2018 Oct 19. J Fr Ophtalmol. 2018. PMID: 30348597 French.
[Update from France Macula Federation: Treatment of Wet AMD].
Tick S, Cornut PL, De Bats F, Wolf B, Souied EH, Cohen SY. Tick S, et al. Among authors: de bats f. J Fr Ophtalmol. 2018 Nov;41(9):862-867. doi: 10.1016/j.jfo.2018.06.002. Epub 2018 Oct 22. J Fr Ophtalmol. 2018. PMID: 30361178 French.
[Management of wet AMD in France in 2015].
Zerbib J, Bourhis A, Cornut PL, De Bats F, Grenet T, Gualino V, Halfon J, Massé H, Srour M, Streho M, Tick S, Wolff B, San Nicolas N. Zerbib J, et al. Among authors: de bats f. J Fr Ophtalmol. 2017 Nov;40(9):723-730. doi: 10.1016/j.jfo.2017.05.009. Epub 2017 Oct 18. J Fr Ophtalmol. 2017. PMID: 29055730 French.
33 results